1998
DOI: 10.1038/3661
|View full text |Cite
|
Sign up to set email alerts
|

Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition

Abstract: The phenylethanolamines, ifenprodil and CP-101,606, are NMDA receptor antagonists with promising neuroprotective properties. In recombinant NMDA receptors expressed in Xenopus oocytes, we found that these drugs inhibit NMDA receptors through a unique mechanism, making the receptor more sensitive to inhibition by protons, an endogenous negative modulator. These findings support a critical role for the proton sensor in gating the NMDA receptor and point the way to identifying a context-dependent NMDA receptor an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

10
199
0

Year Published

2000
2000
2022
2022

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 205 publications
(209 citation statements)
references
References 37 publications
10
199
0
Order By: Relevance
“…The finding that protons appear to shift receptors to an inactive state also carries structural implications and suggests that other forms of allosteric modulation could proceed through creation of briefly occupied inactive states [e.g., calcineurin effects on GluR1 (Banke et al, 2000)]. Given that a number of regulators, such as polyamines, extracellular Zn 2ϩ , ifenprodil, and alternative splicing, all appear to alter NMDA receptor function by shifting the pKa of the proton sensor (Traynelis et al, 1995;Mott et al, 1998;Choi and Lipton, 1999;Low et al, 2000), our findings have widespread implications for NMDA receptor function.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The finding that protons appear to shift receptors to an inactive state also carries structural implications and suggests that other forms of allosteric modulation could proceed through creation of briefly occupied inactive states [e.g., calcineurin effects on GluR1 (Banke et al, 2000)]. Given that a number of regulators, such as polyamines, extracellular Zn 2ϩ , ifenprodil, and alternative splicing, all appear to alter NMDA receptor function by shifting the pKa of the proton sensor (Traynelis et al, 1995;Mott et al, 1998;Choi and Lipton, 1999;Low et al, 2000), our findings have widespread implications for NMDA receptor function.…”
Section: Discussionmentioning
confidence: 99%
“…Allosteric regulators such as polyamines acting at NR1/NR2B NMDA receptors (Traynelis et al, 1995), ifenprodil acting at NR1/NR2B (Mott et al, 1998), and zinc acting at NR1/NR2A (Choi and Lipton, 1999;Low et al, 2000;Paoletti et al, 2000 have been proposed to exert their actions through modification of tonic inhibition by physiological pH. Thus, proton-sensitive gating could be a downstream feature of receptor activation that is regulated by exogenous molecules and therapeutic agents.…”
Section: Introductionmentioning
confidence: 99%
“…However, the nature of this residual response is not clear. If Zn 2ϩ inhibition of NR2A-containing receptors reflected enhancement of proton sensitivity, as has been reported for phenolethanolamines (30), the maximal Zn 2ϩ inhibition would depend on the concentration of protons. Based on the shift of proton curve in the presence of saturating Zn 2ϩ , the proton inhibition at neutral pH is still far from the maximal, resulting in a significant residual response.…”
Section: Mechanism Of the Voltage-independent Zn 2؉ Inhibition Of Nr1mentioning
confidence: 99%
“…A negative allosteric modulator (NAM) of the NR2B subtype of NMDA receptor, CP-101,606 Mott et al, 1998), also evidenced an antidepressant response in patients (Preskorn et al, 2008). Compounds of the NR2B NAM class bind at the interface of the NR2B/ NR1 amino terminal domains to allosterically reduce channel-opening probability to inhibit ion flux and functionally inhibit receptor activity (Karakas et al, 2011;Traynelis et al, 2010).…”
Section: Introductionmentioning
confidence: 99%